Literature DB >> 2190385

Quality assessment of cyclosporine measurements: comparison of current methods.

D W Holt1, J T Marsden, A Johnston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2190385

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

Review 1.  The use of therapeutic drug monitoring to optimise immunosuppressive therapy.

Authors:  S M Tsunoda; F T Aweeka
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

2.  Acute tubular necrosis following high-dose cyclosporine A therapy.

Authors:  P Shechter
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

3.  The risk of coronary artery disease after heart transplantation is increased in patients receiving low-dose cyclosporine, regardless of blood cyclosporine levels.

Authors:  A Gamba; F Mamprin; R Fiocchi; M Senni; G Troise; P Ferrazzi; R Ferrara; G Corbetta
Journal:  Clin Cardiol       Date:  1997-09       Impact factor: 2.882

Review 4.  Prevention and management of graft-versus-host disease. Practical recommendations.

Authors:  G B Vogelsang; L E Morris
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

Review 5.  Therapeutic monitoring of cyclosporin--an update.

Authors:  A Lindholm
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 6.  A review of assay methods for cyclosporin. Clinical implications.

Authors:  K T Kivistö
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.